Dr. M. Janarthinakani
Consultant
23 Years of ExperienceRadiation Oncologist
MBBS, MD
Reg. No.:68150 Tamil Nadu Medical Council
English, Tamil
Consultation Fee ₹ 500
About Dr. M. Janarthinakani
- Dr. M. Janarthinakani is a qualified radiation oncologist with over 23 years of academic and clinical background.
- He is proficient in the use of different radiation therapy techniques, including 3D conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), stereotactic body radiotherapy (SBRT), and stereotactic radiosurgery (SRS).
- Dr. M. Janarthinakani obtained his MBBS degree from Madurai Medical College in 2001 and his MD in Radiation Oncology from the prestigious Cancer Institute (WIA) in 2004 from Chennai.
- He has also completed a certified palliative care training course from Lakshmi Pain & Palliative Care Trust and passed the European Society for Medical Oncology (ESMO) examination.
- Dr. Janarthinakani has served as a co-investigator in several clinical trials, including studies on metastatic colorectal cancer and gastric-esophageal junction cancers.
- Dr. Janarthinakani is a member of the Association of Radiation Oncologists of India (AROI), the Indian Cooperative Oncology Network (ICON), and the Indian Medical Association (IMA).
Book Your Appointment With Dr. M. Janarthinakani
Get a Treatment Plan Within 1 Hour
Education
- MBBS, Madurai Medical College, Tamil Nadu, 2001
- MD in Radiation Oncology, Cancer Institute Adyar (WIA), Chennai, 2004
Training & Certificates
- Certification in Palliative Care, Lakshmi Pain & Palliative Care Trust, Chennai, 2016
Past Experience
- Assistant Professor, Radiation Oncology, Rajiv Gandhi Government General Hospital (RGGH) - Barnard Institute of Radiology (BIRO), Chennai, 2012
- Visiting Consultant, Radiation Oncology, Apollo Hospital, Chennai
- Consultant, Radiation Oncology, Kumaran Hospital, Chennai 2008
- Assistant Professor and Consultant, Radiation Oncology, Government Medical College, Tuticorin, 2007
- Lecturer and Consultant, Radiation Oncology, Cancer Institute Adyar (WIA), Chennai, 2006
Associations/Membership
- Association of Radiation Oncologists of India (AROI)
- Indian Cooperative Oncology Network (ICON)
- Indian Medical Association (IMA)
Paper Published
- Seshachalam, A., Karpurmath, S. V., Rathnam, K., Raman, S. G., Janarthinakani, M., et al. (2019). Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of Global Oncology, 5, 1–13. https://doi.org/10.1200/JGO.19.00179
- Balaji, V., Seshiah, V., Ashtalakshmi, G., Ramanan, S. G., & Janarthinakani, M. (2014). A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population. Indian journal of endocrinology and metabolism, 18(3), 425–427. https://doi.org/10.4103/2230-8210.131223
Field of Expertise
- Acute Lymphoblastic Leukemia Treatment
- Adrenal Cancer Treatment
- Bacillus Calmette Guerin (BCG) Therapy
- Benign and Cancerous Tumor Excision
- Bile Duct Cancer Treatment
- Bone Marrow Transplant
- Brain Tumor Surgery
- Breast Biopsy
- Breast Cancer Treatment
- Cancer Treatment
- CAR T-Cell Therapy
- Carcinoid Tumor Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Chemotherapy
- Chronic Myeloid Leukemia Treatment
- Colon Cancer Surgery
- Colorectal Cancer Treatment
- Completion Thyroidectomy
- Endometrial Cancer Treatment
- Endoscopic Tumor Removal
- Ewing Family of Tumors Treatment
- Fine Needle Aspiration
- Gallbladder Cancer Treatment
- Genitourinary Cancer Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer
- Hormone Therapy
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Image-Guided Radiation Therapy (IGRT)
- Immunotherapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Kaposi Sarcoma Treatment
- Liver Cancer Treatment
- Lumpectomy
- Lung Cancer Treatment
- Malignant Mesothelioma Treatment
- Metastatic Tumor Treatment
- Minimally Invasive Cancer Surgery
- Nasal Cavity and Paranasal Sinus Cancer Treatment
- Nasopharyngeal Cancer Treatment
- Non-Small Cell Lung Cancer (NSCLC) Treatment
- Oncological Surgery
- Ovarian Cancer Treatment
- Papillary Thyroid Cancer Treatment
- Penile Cancer Treatment
- PET CT Scan
- Proton Therapy
- Radiation Therapy
- Radioisotope Therapy
- Rhabdomyosarcoma (RMS) Treatment
- Robotic Cancer Surgery
- Skin Lymphoma Treatment
- Small Intestine Cancer Treatment
- Stomach Cancer Treatment
- Targeted Therapy
- Thymectomy
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Transarterial Chemoembolization (TACE)
- Vaginal Cancer Treatment
- Vulvar Cancer Treatment
- Whipple Procedure
- Acute Lymphoblastic Leukemia (ALL)
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)
- Adenocarcinoma
- Adenosquamous Carcinoma
- Adrenocortical Carcinoma
- Adult Hodgkins Lymphoma
- AIDS-Related Cancer
- Ameloblastoma
- Anal Cancer
- Anaplastic Carcinoma
- Appendix Cancer
- Atypical Hyperplasia
- Atypical Spindle Cell Tumor
- Atypical Teratoid/Rhabdoid Tumor (ATRT)
- Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
- Basal Cell Carcinoma (BCC)
- Basal Cell Carcinoma of the Skin
- Benign Bone Tumors
- Benign Hematology
- Benign Lung Tumors
- Benign Soft Tissue Tumors
- Bile Duct Cancer, Stones, & Strictures
- Bladder Cancer
- Blood Cancer
- Bone Cancer
- Bone Marrow Cancer
- Breast Cancer
- Breast Cancer During Pregnancy
- Breast Cancer Recurrence
- Bronchial Tumors
- Burkitt Lymphoma
- Cancer in Children
- Carcinoid Syndrome
- Carcinoid Tumor (Gastrointestinal)
- Carcinoid Tumors of the Lungs
- Cervical Cancer
- Childhood Acute Lymphoblastic Leukemia
- Cholangiocarcinoma
- Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia
- Chronic Myeloid Leukemia (CML)
- Chronic Myeloproliferative Neoplasms
- Colorectal Cancer
- Cutaneous T-Cell Lymphoma
- Cyclic Neutropenia
- Desmoid Tumor
- Ductal Carcinoma in Situ (DCIS)
- Elevated PSA (Prostate-Specific Antigen) Level
- Embryonal Tumors
- Eosinophilia
- Esophageal Cancer
- Esophagectomy
- Esthesioneuroblastoma
- Estrogen Dependent Cancers
- Ewing Sarcoma
- Extracranial Germ Cell Tumor
- Extragonadal Germ Cell Tumor
- Extrahepatic Bile Duct Cancer
- Fallopian Tube Cancer
- Familial Adenomatous Polyposis (FAP)
- Familial Adenomatous Polyposis (FAP): Inherited
- Follicular Lymphoma
- Free Flap Surgery for Treating Osteoradionecrosis
- Gallbladder Cancer
- Gastric Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Gestational Trophoblastic Disease
- Giant Cell Tumor
- Gum Tumor
- Hairy Cell Leukemia (HCL)
- Head and Neck Cancer
- Heart Cancer
- Hepatocellular Cancer
- Hereditary Non-polyposis Colorectal Cancer (HNPCC)
- Hurthle Cell Carcinoma
- Hypopharyngeal Cancer
- Hypopharyngeal Cancer
- Immunotherapy
- In-situ Breast Cancer
- Incontinence After Prostate Surgery
- Inflammatory Breast Cancer
- Intensity Modulated Radiation Therapy
- Intraocular Melanoma
- Invasive Breast Cancer
- Invasive Lobular Carcinoma
- Islet Cell Tumor
- Kaposi Sarcoma
- Large Cell Carcinoma
- Large Granular Lymphocytic (LGL) leukemia
- Leukemia
- Lip and Oral Cavity Cancer
- Liver Cancer
- Liver Cysts & Liver Tumors
- Lung Cancer
- Lymphatic Cancer
- Lymphocytosis
- Male Breast Cancer
- Malignant Fibrous Histiocytoma (MFH)
- Malignant Mesothelioma
- Malignant Soft Tissue Tumors
- Mediastinal Tumor
- Medullary Carcinoma
- Melanoma
- Merkel Cell Carcinoma
- Metastatic Cancer
- Metastatic Spinal Tumors
- Metastatic Squamous Neck Cancer with Occult Primary
- Metastatic Tumors
- Mouth Cancer
- Multiple Endocrine Neoplasia (MEN) Syndromes
- Multiple Myeloma
- Myelodysplastic Syndromes
- Nasal Cavity and Paranasal Sinus Cancer
- Nasopharyngeal Cancer
- Neuroendocrine Tumor
- Non-Small Cell Lung Cancer
- NUT Midline Carcinoma
- Oncogenic Osteomalacia
- Ophthalmic Cancer
- Oral Cancer
- Oropharyngeal Cancer
- Osteosarcoma
- Ovarian Cancer
- Ovarian Germ Cell Tumors
- Ovarian Primary Peritoneal Cancer
- Ovarian Sex Cord Stromal Tumor
- Pancreatic Cancer
- Pancreatic Neuroendocrine Tumor
- Paraganglioma
- Paraneoplastic Syndromes
- Parathyroid Cancer
- Parotid Gland Tumor
- Pediatric Chordomas
- Pediatric Ependymoma
- Pediatric Germ Cell Tumor
- Pediatric Rhabdomyosarcoma
- Pediatric Spinal Cord Tumor
- Pediatric Spinal Tumor
- Pediatric Vascular Tumors
- Penile Cancer
- Pharyngeal Cancer
- Pheochromocytoma
- Pigmented Villonodular Synovitis (PVNS)
- Pineal Region Tumor
- Plasma Cell Neoplasms
- Pleural Tumor
- Pleuropulmonary Blastoma
- Prostate Cancer
- PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
- Pulmonary Nodules
- Pure Red Cell Aplasia (PRCA)
- Rectal Cancer
- Recurrent Cancer
- Relapsed ALL
- Relapsed AML
- Relapsed Multiple Myeloma
- Renal Cell Cancer
- Retinoblastoma (Cancer of the Eye)
- Retroperitoneal Tumor
- Rhabdomyosarcoma
- Salivary Gland Cancer
- Sarcoma
- Sezary Syndrome
- Skin Cancer
- Skull Base Tumor
- Small Cell Carcinoma
- Small Cell Lung Cancer
- Small Intestine Cancer
- Soft Tissue Sarcoma
- Spinal Tumor
- Squamous Cell Carcinoma (SCC)
- Stage 4 Cancer
- Stomach Cancer
- Sun Exposure & Skin Cancer
- Synovial Sarcoma
- Testicular Cancer
- Throat Cancer
- Thrombocytosis
- Thymoma and Thymic Carcinoma
- Thymus Gland Tumor
- Thyroid Cancer
- Tracheobronchial Tumor
- Transitional Cell Cancer
- Urethral Cancer
- Uterine Sarcoma
- Vaginal Cancer
- Vascular Tumor
- Vulvar Cancer
- Wilms Tumor
Could not find what you are looking for?
No worries — just tell us what you need, and our experts will guide you personally.
Best Oncology Doctors in India
Dr. Mirza Athar Ali
Consultant
Radiation Oncologist
Medicover Cancer Institute Hyderabad
WhatsApp Us
